Therapeutic AAV gene transfer to the nervous system: a clinical reality

E Hudry, LH Vandenberghe - Neuron, 2019 - cell.com
Gene transfer has long been a compelling yet elusive therapeutic modality. First mainly
considered for rare inherited disorders, gene therapy may open treatment opportunities for …

The AAV vector toolkit: poised at the clinical crossroads

A Asokan, DV Schaffer, RJ Samulski - Molecular Therapy, 2012 - cell.com
The discovery of naturally occurring adeno-associated virus (AAV) isolates in different
animal species and the generation of engineered AAV strains using molecular genetics …

Aquaporin-4-dependent glymphatic solute transport in the rodent brain

H Mestre, LM Hablitz, ALR Xavier, W Feng, W Zou… - Elife, 2018 - elifesciences.org
The glymphatic system is a brain-wide clearance pathway; its impairment contributes to the
accumulation of amyloid-β. Influx of cerebrospinal fluid (CSF) depends upon the expression …

Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery

ME Pizzo, DJ Wolak, NN Kumar… - The Journal of …, 2018 - Wiley Online Library
Key points It is unclear precisely how macromolecules (eg endogenous proteins and
exogenous immunotherapeutics) access brain tissue from the cerebrospinal fluid (CSF). We …

Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms

EF Gallo, J Posner - The Lancet Psychiatry, 2016 - thelancet.com
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterised by developmentally inappropriate levels of inattention and hyperactivity or …

[HTML][HTML] Convection-enhanced delivery

AM Mehta, AM Sonabend, JN Bruce - Neurotherapeutics, 2017 - Elsevier
Convection-enhanced delivery (CED) is a promising technique that generates a pressure
gradient at the tip of an infusion catheter to deliver therapeutics directly through the …

Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)

AN Mamelak, DB Jacoby - Expert opinion on drug delivery, 2007 - Taylor & Francis
Targeted therapies for cancer is a rapidly advancing field, but the identification of tumor-
specific ligands has proven difficult. Chlorotoxin (CTX) is a small, 36 amino acid neurotoxin …

[HTML][HTML] Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target

MK Desai, MA Mastrangelo, DA Ryan, KL Sudol… - The American journal of …, 2010 - Elsevier
The detection of myelin disruptions in Alzheimer's disease (AD)–affected brain raises the
possibility that oligodendrocytes undergo pathophysiological assault over the protracted …

Adeno-associated virus vectors and neurological gene therapy

DS Ojala, DP Amara, DV Schaffer - The Neuroscientist, 2015 - journals.sagepub.com
Gene therapy has strong potential for treating a variety of genetic disorders, as
demonstrated in recent clinical trials. There is unfortunately no scarcity of disease targets …

Current trends in targeted therapies for glioblastoma multiforme

F Ohka, A Natsume… - Neurology research …, 2012 - Wiley Online Library
Glioblastoma multiforme (GBM) is one of the most frequently occurring tumors in the central
nervous system and the most malignant tumor among gliomas. Despite aggressive …